RYLDX
Price
$200.64
Change
+$3.42 (+1.73%)
Updated
Dec 3 closing price
Net Assets
39.58M
UOPSX
Price
$101.27
Change
+$0.40 (+0.40%)
Updated
Dec 3 closing price
Net Assets
1.74B
Interact to see
Advertisement

RYLDX vs UOPSX

Header iconRYLDX vs UOPSX Comparison
Open Charts RYLDX vs UOPSXBanner chart's image
Rydex Dow 2x Strategy A
Price$200.64
Change+$3.42 (+1.73%)
VolumeN/A
Net Assets39.58M
ProFunds UltraNASDAQ-100 Svc
Price$101.27
Change+$0.40 (+0.40%)
VolumeN/A
Net Assets1.74B
RYLDX vs UOPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYLDX vs. UOPSX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLDX is a Buy and UOPSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UOPSX has more cash in the bank: 1.74B vs. RYLDX (39.6M). RYLDX pays higher dividends than UOPSX: RYLDX (0.53) vs UOPSX (0.00). RYLDX was incepted earlier than UOPSX: RYLDX (21 years) vs UOPSX (28 years). UOPSX (2.53) is less costly to investors than RYLDX (1.87). RYLDX is a more actively managed with annual turnover of: 1015.00 vs. UOPSX (22.00). RYLDX has a lower initial minimum investment than UOPSX: RYLDX (2500) vs UOPSX (15000). UOPSX annual gain was more profitable for investors over the last year : 24.05 vs. RYLDX (1.61). RYLDX return over 5 years is better than : 85.74 vs. UOPSX (60.43).
RYLDXUOPSXRYLDX / UOPSX
Total Expense Ratio1.772.5370%
Annual Report Gross Expense Ratio1.872.5374%
Fund Existence21 years28 years-
Gain YTD16.28126.90061%
Front Load5%N/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets39.6M1.74B2%
Annual Yield % from dividends0.530.00-
Returns for 1 year1.6124.057%
Returns for 3 years52.00190.8127%
Returns for 5 years85.7460.43142%
Returns for 10 years288.13572.0450%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPMF12.23N/A
N/A
Astellas Pharma, Inc.
AVNBF23.40N/A
N/A
AVON TECHNOLOGIES PLC
ENGGF16.20N/A
N/A
Enagas S.A.
HOFBF0.17N/A
N/A
Hofseth Biocare ASA
FNTTF0.26N/A
N/A
XR IMMERSIVE TECH INC.